The Global Wicked Problem of Corruption and Its Risks for Access to HIV/AIDS Medicines
- 3 August 2018
- journal article
- editorial
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 104 (6) , 1054-1056
Abstract
We discuss how corruption affects access to antiretroviral therapies (ARVs) globally. Recent cases of theft of ARVs, collusion, and manipulation in procurement found in countries such as Central African Republic, Bangladesh, Malawi, and Guinea, show there is still much work to be done to reduce the risk of corruption. This includes addressing the structural weaknesses in procurement mechanisms and supply chain management systems of health commodities and medicines.Keywords
This publication has 6 references indexed in Scilit:
- The impact of HIV prevalence, conflict, corruption, and GDP/capita on treatment cascades: data from 137 countriesJournal of Virus Eradication, 2018
- Combating corruption in global healthScience Translational Medicine, 2017
- A review of existing and emerging digital technologies to combat the global trade in fake medicinesExpert Opinion on Drug Safety, 2017
- Substandard/Counterfeit Antimicrobial DrugsClinical Microbiology Reviews, 2015
- Why the MDGs need good governance in pharmaceutical systems to promote global healthBMC Public Health, 2014
- Understanding Wicked Problems: A Key to Advancing Environmental Health PromotionHealth Education & Behavior, 2004